Colonoscopy Devices Market Analysis, Outlook, Size by 2030
Perspectivas del mercado y visión de analista:
El pronóstico del mercado de dispositivos de colonoscopia puede ayudar a las partes interesadas en este mercado a planificar sus estrategias de crecimiento. El informe incluye perspectivas de crecimiento, junto con las tendencias del mercado de dispositivos de colonoscopia y su impacto previsible durante el período de pronóstico.
Las colonoscopias se realizan con endoscopios reutilizables. Son instrumentos flexibles de fibra óptica que se introducen en el ano y se dirigen a través del colon. Los colonoscopios ayudan a los endoscopistas a detectar enfermedades crónicas y controlar a los pacientes en busca de enfermedades malignas o precancerosas. Las personas de 50 años o más deben hacerse colonoscopias como parte de un régimen regular de detección del cáncer. En hospitales o centros de cirugía ambulatoria (ASC), los procedimientos se llevan a cabo bajo sedación suave. La creciente prevalencia del cáncer colorrectal y los crecientes avances tecnológicos en los dispositivos de colonoscopia por parte de los fabricantes contribuyen al creciente tamaño del mercado de dispositivos de colonoscopia. Sin embargo, la disponibilidad de pruebas de diagnóstico alternativas para enfermedades rectales impide el crecimiento del mercado.
Impulsores de crecimiento:
La creciente prevalencia del cáncer colorrectal impulsa el crecimiento del mercado de dispositivos de colonoscopia
Cáncer colorrectal Es un tumor maligno que se forma en los tejidos del recto o del colon. El cáncer de recto y de colon a menudo se agrupan debido a las características comunes de ambas afecciones. Según la Organización Mundial de la Salud (OMS), el cáncer de colon ocupa el segundo lugar en términos de muertes relacionadas con el cáncer en todo el mundo. A nivel mundial, hubo más de 1,9 millones de nuevos casos de cáncer colorrectal y más de 930.000 muertes por la enfermedad en 2020. Hubo diferencias regionales significativas en las tasas de incidencia y mortalidad. Europa, Australia y Nueva Zelanda informaron las tasas de incidencia más altas, mientras que Europa del Este tuvo las tasas de mortalidad más altas. Según los datos proporcionados por el Sistema Europeo de Información sobre el Cáncer, en los países de la UE-27, el cáncer colorrectal representó el 12,7% de todos los nuevos diagnósticos de cáncer y el 12,4% de la mortalidad total causada por la enfermedad en 2020. La alta prevalencia lo convierte en el segundo más frecuente. cáncer, después del cáncer de mama, y la segunda causa de muerte, después del cáncer de pulmón, en Europa. Según la OMS, en 2020 hubo más de 1,9 millones de nuevos casos de cáncer colorrectal, se espera que la carga anual de cáncer colorrectal aumente a 3,2 millones de nuevos casos (un aumento del 63%) y 1,6 millones de muertes (un aumento del 73%). ) para 2040.
En los EE. UU., el cáncer colorrectal es el tercer tipo de cáncer más común (excluyendo el cáncer de piel) detectado cada año. Según la Sociedad Estadounidense del Cáncer, en 2023, ~153 000 personas fueron diagnosticadas con cáncer colorrectal en el país. Estas cifras incluyen 106.950 nuevos casos de cáncer de colon (54.420 hombres y 52.550 mujeres) y 46.050 nuevos casos de cáncer de recto (27.440 hombres y 18.610 mujeres). Para el cáncer colorrectal, la colonoscopia es una prueba de detección importante y se ha convertido en parte de la detección sistemática del cáncer. Por lo tanto, la creciente prevalencia del cáncer colorrectal impulsa el crecimiento del mercado de dispositivos de colonoscopia.
Las alternativas a la colonoscopia incluyen la sigmoidoscopia, una forma menos invasiva de colonoscopia, y la prueba de muestras de heces, uno de los métodos no invasivos. Desde principios del siglo XXI, los médicos han recomendado ampliamente la colonoscopia para detectar cáncer de colon en pacientes de 50 años o más. Sin embargo, en los últimos años han sentido la necesidad de un cambio de táctica. Les preocupa el costo y las molestias de la colonoscopia, lo que desalienta a las personas a someterse a estos procedimientos de detección. Además, existen pruebas igualmente efectivas que son menos invasivas y menos complicadas que una colonoscopia. Por lo tanto, la disponibilidad de pruebas de diagnóstico alternativas obstaculiza el crecimiento del mercado de dispositivos de colonoscopia.
Segmentación y alcance del informe:
El análisis del mercado de dispositivos de colonoscopia ha sido realizado por considerando los siguientes segmentos: tipo de producto, aplicación y usuario final.
Análisis segmentario:
Por tipo de producto, el mercado de dispositivos de colonoscopia se segmenta en colonoscopios, sistemas de visualización y otros. El segmento de colonoscopios tuvo la mayor cuota de mercado en 2022. Sin embargo, se prevé que el segmento de sistemas de visualización registre la CAGR más alta durante 2022-2030.
Mercado de dispositivos de colonoscopia, por tipo de producto: 2022 y 2030
br>El mercado de dispositivos de colonoscopia, por aplicación, se segmenta en cáncer colorrectal, síndrome de Lynch, colitis ulcerosa, enfermedad de Crohn y otros. El segmento de cáncer colorrectal tuvo la mayor participación de mercado de dispositivos de colonoscopia en 2022, y se prevé que el mismo segmento registre la CAGR más alta durante 2022-2030. La colonoscopia puede detectar y eliminar lesiones malignas y promalignas con gran precisión. Es una valiosa herramienta de diagnóstico para la detección del cáncer colorrectal. Casi todas las sociedades gastrointestinales y oncológicas nacionales e internacionales recomiendan utilizarlo como primer método de detección.
El mercado de dispositivos de colonoscopia, por usuario final, está segmentado en hospitales, centros de cirugía ambulatoria y otros. El segmento hospitalario tuvo la mayor participación de mercado de dispositivos de colonoscopia en 2022 y se prevé que registre la CAGR más alta durante 2022-2030, debido a la adopción de avances tecnológicos en los hospitales y al creciente número de exámenes de detección en entornos hospitalarios.
Análisis regional:
El alcance geográfico del informe de mercado de dispositivos de colonoscopia incluye América del Norte, Europa, Asia Pacífico, Medio Oriente y África, y América del Sur y Central. América del Norte tuvo la mayor cuota de mercado en 2022. El crecimiento del mercado en América del Norte está impulsado por la creciente carga del envejecimiento de la población, el creciente número de lanzamientos de productos y las actividades de I+D para desarrollar dispositivos avanzados de colonoscopia.
Panorama competitivo y claves Empresas:
AMBU AS, Fujifilm, Endomed Systems gmbh, Olympus, Steris PLC, GI View, Boston Scientific Corporation, PENTAX Medical, Avantis Medical Systems y SonoScape Medical Corp se encuentran entre las empresas destacadas perfiladas en el sector de dispositivos de colonoscopia. informe del Mercado. Estas empresas se centran en desarrollar nuevas tecnologías, actualizar productos existentes y ampliar su presencia geográfica para satisfacer la creciente demanda de los consumidores en todo el mundo. Según los comunicados de prensa de la empresa, a continuación se presentan algunos desarrollos clave recientes:
En abril de 2021, FUJIFILM Medical Systems lanzó el colonoscopio serie G-EYE 700. G-EYE, una tecnología desarrollada por Smart Medical, ayuda durante los exámenes de rutina. Los colonoscopios de la serie G-EYE 700 ampliaron la innovadora oferta de colonoscopios de Fujifilm. G-EYE se ofrecerá como una extensión de la familia de colonoscopios de la serie 700 que es compatible con el sistema de imágenes de video endoscópico ELUXEO de Fujifilm. En octubre de 2020, Olympus recibió la autorización 510(k) y la disponibilidad en el mercado de sus dos colonoscopios: PCF-H190T y PCF-HQ190. Los productos ampliaron las capacidades actuales de los médicos para diagnosticar y tratar trastornos del tracto gastrointestinal.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The colonoscopy devices market majorly consists of players such as AMBU AS, Fujifilm, Endomed systems gmbh, Olympus, Steris PLC, GI View, Boston Scientific Corporation, PENTAX Medical, Avantis Medical Systems, and SonoScape Medical Corp among others.
US holds the largest market share in colonoscopy devices market due to the increasing public awareness of colon cancer through media campaigns initiated by cancer awareness groups and government agencies, and an aging population who are encouraged to have regular checkups. According to the American Cancer Society, an estimated 104,610 new colon cancer cases and 43,340 rectal cancer cases were diagnosed in the US in 2020.
The factors that are driving the growth of the market are the rising prevalence of colorectal cancer and increasing technological advancements in colonoscopy devices by manufacturers.
Asia Pacific is expected to be the fastest-growing region in the colonoscopy devices market. The colonoscopy devices market in the region is driven by factors such as an increasing number of R&D activities, adoption of innovative technology and products, and upsurging prevalence of chronic diseases in this region.
Colonoscopies are performed with reusable scopes. They are flexible, fiber-optic instruments that are introduced into the anus and directed through the colon. The colonoscopes helps endoscopists detect chronic illnesses and check patients for malignant or precancerous diseases. People aged 50 years and above should get colonoscopies as part of a regular cancer screening regimen. In hospitals or ambulatory surgery center (ASCs), the procedures are carried out under mild sedation.
The colonoscopy devices market, based on end user, is segmented hospitals, ambulatory surgery centers, and others. The hospital segment held the largest colonoscopy devices market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The colonoscopy devices market, based on product type, is segmented into colonoscope visualization systems, and others. The colonoscope segment held the largest market share in 2022. However, the visualization systems segment is anticipated to register the highest CAGR during 2022– 2030.
The colonoscopy devices market, based on application, is segmented into colorectal cancer, lynch syndrome, ulcerative colitis, Crohn's disease, and other. The colorectal cancer segment held the largest colonoscopy devices market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030.
The List of Companies - Colonoscopy Devices Market
- AMBU AS
- Fujifilm
- Endomed systems gmbh
- Olympus
- Pentax
- GI View
- Boston Scientific Corporation
- Steris PLC
- Avantis Medical Systems
- SonoScape Medical Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.